Children's Medical Center Dallas
Pauline Allen Gill
Center for Cancer and Blood Disorders
1935 Medical District Drive
Dallas, TX 75235
Direct phone: (214) 456-2382
Total transplants by cell source
- Marrow: 27
- PBSC: 15
- Cord Blood: 8
- Autologous (PBSC or Marrow): 18
About the center
Our program offers pediatric and adolescent transplant services using related/unrelated donor stem cells and cord blood. Services include pre-transplant assessment, compatibility testing of donor/recipient, psychosocial assistance, extensive education and comprehensive post-transplant follow-up care.
This center has been performing allogeneic transplants since 1992 and has been an NMDP/Be The Match transplant center since April 2002.
Pediatric - Victor Aquino, Erin Butler, Kathryn Dickerson, Jessica Garcia, Samuel John, Andy Koh, Ted Laetsch, An Pham, Ksenya Shliakhtsitsava, Tiffany Simms-Waldrip, Tanya Watt, Ayesha Zia
Marrow/PBSC, single cord, and double cord
Cord blood transplants performed on
Other programs and services
Our program offers pediatric and adolescent transplant services using related/unrelated donor stem cells and cord blood. Services include pre-transplant assessment, compatibility testing of donor/recipient, psychosocial assistance, extensive education, and comprehensive post-transplant follow-up care. Lodging accommodations are available at the Ronald McDonald House. Our Social Work team also works with families to assist with arrangements for travel and lodging.
Overall center survival
Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center.
The survival information we have for this center includes ONLY:
- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2017, 2018, 2019, and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 71 patients.
The actual 1-year survival of these patients is 85.8%.
Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 77.2% and 93.2%.
For help with understanding these statistics, please see Understanding Transplant Outcomes.
For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.
Transplants reported (From January 1, 2019 to December 31st, 2020 as reported by the centers)
|Both marrow & PBSC
Transplants by disease
Number of transplants by age reported from January 1, 2019 to December 31st, 2020 (includes marrow, PBSC and cord blood)
Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants for this disease can be found:
Transplant center resources
Transplant center coordinator:
Be The Match patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)